Johansson Niklas G, Dreano Loïc, Vidilaseris Keni, Khattab Ayman, Liu Jianing, Lasbleiz Arthur, Ribeiro Orquidea, Kiriazis Alexandros, Boije Af Gennäs Gustav, Meri Seppo, Goldman Adrian, Yli-Kauhaluoma Jari, Xhaard Henri
Drug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki, P.O. Box 56 (Viikinkaari 5 E), 00014, Helsinki, Finland.
Department of Biosciences, Division of Biochemistry, University of Helsinki, P.O. Box 56 (Viikinkaari 9), 00014, Helsinki, Finland.
ChemMedChem. 2021 Nov 5;16(21):3360-3367. doi: 10.1002/cmdc.202100392. Epub 2021 Oct 12.
Inhibition of membrane-bound pyrophosphatase (mPPase) with small molecules offer a new approach in the fight against pathogenic protozoan parasites. mPPases are absent in humans, but essential for many protists as they couple pyrophosphate hydrolysis to the active transport of protons or sodium ions across acidocalcisomal membranes. So far, only few nonphosphorus inhibitors have been reported. Here, we explore the chemical space around previous hits using a combination of screening and synthetic medicinal chemistry, identifying compounds with low micromolar inhibitory activities in the Thermotoga maritima mPPase test system. We furthermore provide early structure-activity relationships around a new scaffold having a pyrazolo[1,5-a]pyrimidine core. The most promising pyrazolo[1,5-a]pyrimidine congener was further investigated and found to inhibit Plasmodium falciparum mPPase in membranes as well as the growth of P. falciparum in an ex vivo survival assay.
用小分子抑制膜结合焦磷酸酶(mPPase)为对抗致病性原生动物寄生虫提供了一种新方法。mPPase在人类中不存在,但对许多原生生物至关重要,因为它们将焦磷酸水解与质子或钠离子跨酸性钙小体膜的主动转运偶联起来。到目前为止,仅报道了少数非磷抑制剂。在这里,我们结合筛选和合成药物化学方法探索先前活性化合物周围的化学空间,在嗜热栖热菌mPPase测试系统中鉴定出具有低微摩尔抑制活性的化合物。此外,我们还围绕具有吡唑并[1,5-a]嘧啶核心的新骨架提供了早期构效关系。对最有前景的吡唑并[1,5-a]嘧啶同系物进行了进一步研究,发现其可抑制恶性疟原虫膜中的mPPase以及在体外存活试验中抑制恶性疟原虫的生长。